Recherche clinique


Déroulement d'une étude :







Acronyme et titre

Source du financement



ALCHEMIST - ALdosterone antagonist Chronic HEModialysis Interventional Survival Trial

Academic (PHRC N 2011)

Under discussion


BOKID - Bariatric Surgery for Obese Patients With Chronic Renal Insufficiency

Academic (PHRC N 2014)

Being carried out 

  COVERT MI - COlchicine for Left Ventricular Remodeling Treatment in Acute Myocardial Infarction


Academic PHRC N 2016 Being set up  

EPURE TRANSPLANT - Double-blind Placebo-Controlled Randomised Clinical Trial of Mineralocorticoid Receptor Blockade With Eplerenon After Renal Tranplantation : Effect on Graft Function at 3 Months.

Academic (PHRC inter régional 2014)

Being set up


ESTIM HTN - Economic Evaluation of Baroreceptor STIMulation for the Treatment of Resistant HyperTensioN

Academic (PRME 2013)

Under investigation

HYPO ECMO - Effects of Induced Moderate HYPOthermia on mortality in Cardiogenic Shock Patients Rescued by Arterio-Venous Extracorporeal Membrane Oxygenation (ECMO)

Academic (PHRC national 2015)

Being set up



LIPS - study (Lanreotide In Polycystic kidney disease Study) is a prospective randomized double blind placebo controlled study. The main objective is to prove that lanreotide, a somatostatin analog, is able to reduce the glomerular filtration rate decline over 3 years by at least 30%. Cardiovascular outcomes, blood pressure, quality of life and safety are among the secondary outcomes. The study, which will include 180 ADPKD patients, is scheduled to start in early 2014.

Academic (PHRC N 2014)



STOP OR NOT - Impact of Renin-Angiotensin System inhibitors continuation on outcome after major surgery: single blind randomized study

Academic (PHRC  N 2016)

Being set up







    Grand Nancy Ville de Nancy Société de Néphrologie






Ministère de la santé



Université de Lorraine


Fondation NIT

Contact :


CRCT Cardiovascular & Renal Clinical Trialists


4, rue du Morvan

54500 VANDOEUVRE-LES-NANCY - FRANCE  - +33 3 83 15 74 39